CEO of Katahdin and President of DCHN. Prior to his involvement with Katahdin, Tim spent 14 years in the chemical industry running two specialty chemical subsidiaries of Cabot Corporation with combined revenue of $85 million. Tim ran and repositioned two subsidiaries, allowing them to grow three times faster than the overall market through the commercialization of incremental and new product technology platforms, expansion in higher growth AP markets, manufacturing cost reductions for older products, reduced SG&A costs, enhanced price management and introduction of long-term supply agreements. Tim is on the board of directors of Southworth International, a $45 million manufacturer of machine handling equipment, based in Falmouth, Maine and Community Resources for Justice, a $30 million Boston-based nonprofit providing services and policy development for the developmentally challenged, at-risk youth and criminal offenders. He received a BA from Columbia University in 1989.
Treasurer of Katahdin and President of Precision Coating. Bob has over 25 years of consulting, manufacturing and medical device experience. Prior to Katahdin, Bob spent 16 years at Cabot Corporation working in and running commodity chemical businesses. As North American Rubber Blacks Business Director, Bob was responsible for $200 million in revenue for the tire and industrial products market segment. He negotiated in excess of $300 million in global sales contracts with three tier-1 global tire manufacturers and established a new global relationship for Cabot's largest customer, with sales in 21 countries and revenue of $200 million. Other positions held at Cabot were E-Business Director, CFO for the Carbon Black and FMO Divisions, and Project Finance Manager for Distrigas (LNG importation company). Bob is on the board of directors of Education Network Technologies (EdNets), an internet-based affinity marketing company for the K-12 education market. He received a BS from Northeastern University in 1984 and received an MBA from Harvard Business School in 1991.
CFO and EVP Corporate Development of Katahdin. Prior to joining Katahdin, Steve was a Managing Director at Consilium Partners, an investment banking firm he co-founded in 2000. Prior to Consilium, Steve was a Director in the Mergers and Acquisitions Group at BancBoston Robertson Stephens Inc., where he was responsible for initiating and executing strategic advisory engagements involving mergers and acquisitions, recapitalizations, acquisition financings and fairness opinions. Steve also headed the Transaction Development Group, which focused on transactions involving financial sponsors, and also specialized in transactions in the consumer and industrial growth sectors. Previously, Steve worked in BankBoston's High Technology Lending Division, where his experience included leveraged acquisitions and recapitalizations, as well as domestic and international financing for growth companies. Steve holds BS (1987) and MS (1988) degrees in Electrical Engineering from Brown University.
COO and GM of DCHN and President of Sanford Process Corporation. From 1999 through 2008, Jack was GM of CHN Metal Finishing, where he led the integration of separate CHN facilities into a purpose-built new metal finishing line in Woonsocket. Jack also led CHN in its merger with Duralectra in 2008. Jack brings extensive operations and marketing experience, having entered the metal finishing industry in 1976.
Chief Technology Officer, Rick LaPorte is responsible for driving the development of core technologies across all of Katahdin,Äôs business units, including Precision Coating (PTFE applications), DCHN (metal finishing), and Medi-Solve (hydrophilic coatings). Rick develops and oversees the engineering organization at each business unit, and leads major initiatives for measuring and enhancing process capability, including the application of new technologies, to maintain technological leadership in the fields that Katahdin serves.
Rick previously was the VP of Engineering at Medi-Solve Coatings. His prior experience includes roles as Director of Development and Pilot Operations at Angiotech Pharmaceuticals, Inc., Program Manager at Medtronic, Inc., and various engineering roles at Boston Scientific Corporation.